STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

EW EDWARDS LIFESCIENCES CORPORATION StockScouter® Report

4

StockScouter® Score

EDWARDS LIFESCIENCES CORPORATION, a large cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is above average. Positive/Neutral
  • Moving average analysis for EW suggests upward price movement over the medium term. Positive

 

Concerns

  • The ratio of EW’s forward price-to-earnings multiple to its estimated growth rate is well above the average of comparably-sized companies in the StockScouter universe. Negative
  • The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 80% done.
Low
High

Core Model Grades

C
D
D
B

Previous Ratings

4
4
4